Send us an email at covidcpg.ph@gmail.com for any questions or clarifications on the outputs and process of this Living CPG. You may also suggest a clinical question for the consideration of the Living Clinical Practice Guidelines COVID-19 Taskforce.
As a living guideline, the recommendations will be updated, and new recommendations will be added as the evidence evolves. The living recommendations are based on the best evidence available in scientific literature at the time of its formulation. However, this living CPG is not a comprehensive guide to all practice questions and management options on COVID-19. This is not meant to restrict the practitioner in using sound clinical judgement and sharing the decision with the patient, and from considering other management options according to the patient’s particular needs and preferences. This CPG can serve to inform policy, but it is not meant to serve as a basis for approving or denying financial coverage or insurance claims merely because of nonconformance with recommendations. Neither are the recommendations supposed to be considered as legal rules for dictating certain modes of action to the exclusion of others.
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 10 pages.
Return to Philippine COVID-19 Living Recommendations.
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 8 pages.
Return to Philippine COVID-19 Living Recommendations.
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 28 pages.
Return to Philippine COVID-19 Living Recommendations.
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 22 pages.
Return to Philippine COVID-19 Living Recommendations.
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 9 pages.
Return to Philippine COVID-19 Living Recommendations.
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 17 pages.
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 5 pages.
Return to Philippine COVID-19 Living Recommendations.
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.